Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: Case report and literature review

Renal Failure

Volumn 35, Issue 3, 2013, Pages 414-417

  Mavrakanas, Thomas A ^a   Bouatou, Yassine ^a   Samer, Caroline ^a   De Seigneux, Sophie ^a   Meyer, Patrick ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

ANCA; Carbimazole; Glomerulonephritis; Graves disease; Hemodialysis; Pauci immune

Indexed keywords

CARBIMAZOLE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; MESNA; ANTITHYROID AGENT;

AGED; ANTI NEUTROPHIL CYTOPLASMIC ANTIBODIES ASSOCIATED RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; ARTICLE; CASE REPORT; DRUG MEGADOSE; EDEMA; GRAVES DISEASE; HEMATURIA; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY TEST; MALE; PRIORITY JOURNAL; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; ANCA ASSOCIATED VASCULITIS; CHEMICALLY INDUCED; COMPLICATION; GLOMERULONEPHRITIS; KIDNEY FAILURE, CHRONIC;

AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTITHYROID AGENTS; CARBIMAZOLE; GLOMERULONEPHRITIS; GRAVES DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE;

EID: 84875041532     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.760356     Document Type: Article

References (42)

1. Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid. 2000;10:595-599
2. Calañas-Continente A, Espinosa M, Manzano-García G, Santamaria R, Lopez-Rubio F, Aljama P. Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy. Thyroid. 2005;15:286-288
3. D'Cruz D, Chesser AM, Lightowler C, et al. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol. 1995;34:1090-1091
4. Day C, Bridger J, Rylance P, Jackson M, Nicholas J, Odum J. Leukocytoclastic vasculitis and interstitial nephritis with carbimazole treatment. Nephrol Dial Transplant. 2003;18:429-431
5. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-Associated autoimmune diseases induced by antithyroid drugs: Comparison with idiopathic ANCA vasculitides. Arthritis Res Ther. 2005;7: R1072-R1081
6. Herlin T, BirkebaekNH, WolthersOD,HeegaardNH, Wiik A. Antineutrophil cytoplasmic antibodies (ANCA) prophiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism. Scand J Rheumatol. 2002;31:46-49
7. Gunton JE, Stiel J, Caterson RJ, McElduff A. Clinical case seminar: Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis.Acase report and review of the literature. J Clin Endocrinol Metab. 1999;84:13-16
8. Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic auto-Antibody-Associated vasculitis. Rheumatology. 2008;47:1515-1520
9. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr. 1994;124:986-988
10. Batchelor N, Holley AA. Fatal case of propylthiouracil-induced ANCA-positive vasculitis. MDMedGenMed. 2006;8:10
11. Wiik A. Clinical and laboratory characteristics of drug-induced vasculitic syndromes. Arthritis Res Ther. 2005;7:191-192
12. Tieulie N, Huong DL, Andreu M, et al. ANCA associated glomerulonephritis related to benzylthiouracil. Rev Med Int. 2002;23:853-856
13. Trimeche Ajmi S, Braham R, Toumi S, et al. Benzylthiouracilinduced glomerulonephritis. Case Report Med. 2009;2009:687285
14. Jarraya F, Abid M, Jlidi R, et al. Myeloperoxidase-Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with benzylthiouracil therapy: Report of the first case. Nephrol Dial Transplant. 2003;18:2421-2423
15. Kaaroud H, Khiari K, Ben Moussa F, Barbouch S, Boussema E, Ben Maïz H. Vasculitis with renal and pulmonary involvement in a patient receiving benzyl thiouracil for Graves disease. Rev Med Int. 2002;23:857-861
16. Erten Y, Bodur H, Sahiner S, Akkaya V, Canbakan B, BaliM. Antineutrophil cytoplasmic antibody associated vasculitis and rapidly progressive glomerulonephritis as a complication of propylthiouracil therapy. Clin Endocrinol. 2002;57:699-700
17. Winters MJ, Hurley RM, Lirenman DS. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol. 2002;17:257-260
18. [18[1] Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid. 2000;10:595-599
19. Calañas-Continente A, Espinosa M, Manzano-García G, Santamaria R, Lopez-Rubio F, Aljama P. Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy. Thyroid. 2005;15:286-288
20. D'Cruz D, Chesser AM, Lightowler C, et al. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol. 1995;34:1090-1091
21. Day C, Bridger J, Rylance P, Jackson M, Nicholas J, Odum J. Leukocytoclastic vasculitis and interstitial nephritis with carbimazole treatment. Nephrol Dial Transplant. 2003;18:429-431
22. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-Associated autoimmune diseases induced by antithyroid drugs: Comparison with idiopathic ANCA vasculitides. Arthritis Res Ther. 2005;7: R1072-R1081
23. Herlin T, BirkebaekNH, WolthersOD,HeegaardNH, Wiik A. Antineutrophil cytoplasmic antibodies (ANCA) prophiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism. Scand J Rheumatol. 2002;31:46-49
24. Gunton JE, Stiel J, Caterson RJ, McElduff A. Clinical case seminar: Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis.Acase report and review of the literature. J Clin Endocrinol Metab. 1999;84:13-16
25. Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic auto-Antibody-Associated vasculitis. Rheumatology. 2008;47:1515-1520
26. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr. 1994;124:986-988
27. Batchelor N, Holley AA. Fatal case of propylthiouracil-induced ANCA-positive vasculitis. MDMedGenMed. 2006;8:10
28. Wiik A. Clinical and laboratory characteristics of drug-induced vasculitic syndromes. Arthritis Res Ther. 2005;7:191-192
29. Tieulie N, Huong DL, Andreu M, et al. ANCA associated glomerulonephritis related to benzylthiouracil. Rev Med Int. 2002;23:853-856
30. Trimeche Ajmi S, Braham R, Toumi S, et al. Benzylthiouracilinduced glomerulonephritis. Case Report Med. 2009;2009:687285
31. Jarraya F, Abid M, Jlidi R, et al. Myeloperoxidase-Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with benzylthiouracil therapy: Report of the first case. Nephrol Dial Transplant. 2003;18:2421-2423
32. Kaaroud H, Khiari K, Ben Moussa F, Barbouch S, Boussema E, Ben Maïz H. Vasculitis with renal and pulmonary involvement in a patient receiving benzyl thiouracil for Graves disease. Rev Med Int. 2002;23:857-861
33. Erten Y, Bodur H, Sahiner S, Akkaya V, Canbakan B, BaliM. Antineutrophil cytoplasmic antibody associated vasculitis and rapidly progressive glomerulonephritis as a complication of propylthiouracil therapy. Clin Endocrinol. 2002;57:699-700
34. Winters MJ, Hurley RM, Lirenman DS. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol. 2002;17:257-260
35. Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron. 1996;74:734-735
36. Yuksel C, Ayli MD, Yuksel A, et al. Propylthiouracil-induced vasculitis associated with ANCA: A case report. Renal Fail. 2007; 29:235-237
37. Braham A, Houman MH, Rais L, Ben Gborbel I, Lamloum M, Miled M. Benzylthiouracil induced ANCA-positive vasculitis. Presse Med. 2004;33:1331-1333
38. Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase-Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: Report of three adult cases. Am J Kidney Dis. 1995;26:774-780. © 2013 Informa Healthcare USA, Inc. Carbimazole-Induced ANCA-Associated Glomerulonephritis
39. Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron. 1996;74:734-735
40. Yuksel C, Ayli MD, Yuksel A, et al. Propylthiouracil-induced vasculitis associated with ANCA: A case report. Renal Fail. 2007; 29:235-237
41. Braham A, Houman MH, Rais L, Ben Gborbel I, Lamloum M, Miled M. Benzylthiouracil induced ANCA-positive vasculitis. Presse Med. 2004;33:1331-1333
42. Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase-Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: Report of three adult cases. Am J Kidney Dis. 1995;26:774-780